- 7326Accesses
- 54Citations
- 11Altmetric
- 1Mention
Metrics
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
Last updated: Wed, 28 Oct 2026 16:22:24 UTC
Accesses
Accesses is an approximate count of unique views and downloads. This number can fluctuate depending on multiple factors.
We update counts daily.
7326 Accesses
Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
54Citations
Altmetric
- 5 tweeters
- 1 news outlets
- 59 Mendeley
Altmetric calculates a score based on the online attention an article gets — the higher the score, the more online attention an article has received.
The donut visual summarises attention from different sources such as social media and news outlets. A breakdown is shown in the legend.
Older articles have had more time to get noticed, so Altmetric provides context data for articles of a similar age.
This article is in the 81st percentile (ranked 59,509th) of the 326,487 tracked articles of a similar age in all journals and the 93rd percentile (ranked 3rd) of the 48 tracked articles of a similar age in Annals of Hematology.
View more on Altmetric.
This list highlights individual mainstream news articles and blogs that cite the article.
Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media.
Altmetric are responsible for the curation of this list and provide updates hourly.